-
-
-
-
-
-
-
Defender Capital opposes STAAR Surgical sale to Alcon ahead of vote
-
-
-
-
-
-
-
Alcon raises STAAR acquisition price to $30.75 per share
-
-
-
-
-
-
-
Yunqi Capital urges STAAR shareholders to reject Alcon merger after Q3 results
-
-
-
-
-
-
-
Yunqi Capital issues new letter to STAAR Surgical (STAA) Board
-
-
-
-
-
-
-
Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon
-
-
-
-
-
-
-
STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims
-
-
-
-
-
-
-
STAAR Surgical (STAA) Tops Q2 EPS by 22c
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

